Charles River Laboratories International (CRL) Cash from Financing Activities (2009 - 2025)

Charles River Laboratories International's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$51.9 million for Q4 2025.

• In Q4 2025, Cash from Financing Activities rose 31.65% year-over-year to -$51.9 million; the TTM figure through Dec 2025 stood at -$536.7 million (up 2.58% YoY), while the FY2025 annual figure was -$536.7 million, up 2.58% from the prior year.
• Cash from Financing Activities was -$51.9 million for Q4 2025 at Charles River Laboratories International, up from -$152.6 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $518.0 million in Q2 2021 to a low of -$285.9 million in Q2 2024.
• Historically, Cash from Financing Activities has averaged -$27.1 million across 5 years, with a median of -$61.7 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Cash from Financing Activities soared 597.57% in 2021, then tumbled 674.1% in 2025.
• A 5-year view of Cash from Financing Activities shows it stood at -$219.0 million in 2021, then retreated by 13.69% to -$249.0 million in 2022, then jumped by 149.63% to $123.6 million in 2023, then tumbled by 161.41% to -$75.9 million in 2024, then soared by 31.65% to -$51.9 million in 2025.
• The last three Cash from Financing Activities figures came in at -$51.9 million (Q4 2025), -$152.6 million (Q3 2025), and -$226.9 million (Q2 2025), per Business Quant data.